feed,title,long_url,short_url
Yahoo,Biogen Stock Pops After FDA Extends Review For Key Alzheimer's Drug,https://www.investors.com/news/technology/biogen-stock-pops-fda-extends-review-key-alzheimers-treatment/?src=A00220&yptr=yahoo,https://j.mp/3ov1S2X
